The Cathedral Trap: Why Pre-Series A Medtech Founders Lock In the Wrong Supplier

The investor asks: “What’s your supply chain plan?” It’s month four of fundraising. You don’t have a clean answer. So you do what feels responsible: run a proper RFQ. Score the responses. Pick the best supplier. Get it on the slide.

Three months later, a geometry change. The supplier quotes six weeks and a $7,000 engineering change order. You’re surprised. You qualified them carefully.

That’s the Cathedral trap. Not that you qualified badly. That you qualified for the wrong moment, with the wrong frame.

The instinct comes from the right place #

The approach: qualify carefully, lock it in, move on. That’s the Cathedral approach to supply chain. It works for big medtech. Stable designs. Deep capital. Timelines measured in years. When you’re running a commercial operation with a frozen design and predictable volumes, locking your supply chain in place is exactly right.

Pre-Series A is a different company. Your design will change. Your batch sizes will shift by orders of magnitude. Your capital is constrained. Your investor milestones compress everything around them.

A qualification process that assumes any of this stays stable is a process that’s going to break.

Why founders fall into it anyway #

Investor pressure arrives before most founders know what their supply chain looks like. “Show us your supply chain plan” demands an answer, so founders lock one in. A qualified supplier feels like a credible answer. For the moment, it is. The problem is that the moment passes and the supplier doesn’t.

The physical weight of sourcing makes decisions feel permanent. Software founders carry agile vocabulary into hardware easily, until they hit purchase orders and tooling invoices. Those feel final. Qualifying a supplier takes months. It’s hard to imagine undoing it. So founders treat the selection as fixed, even when it doesn’t have to be.

The frameworks they reach for were written for scaled operations. Most supplier qualification guides assume a stable design and a production-ready product. They’re not wrong. They’re aimed at a different company than yours.

What the trap costs #

When you’re locked into the wrong supplier at the wrong stage, the costs aren’t obvious at first. The samples look good. The early runs go fine.

The costs show up when something changes. A geometry revision that should take two weeks takes eight. An urgent batch gets deprioritized because you’re too small for their production schedule. A quality issue surfaces and the root cause conversation becomes a document exchange that drags for months.

None of this is malice. It’s fit. The supplier was right for the stage you were in when you qualified them. They’re wrong for the stage you’re in now.

Qualification is a stage, not a destination #

The supplier that gets you through prototype is rarely the right one for clinical. The clinical supplier is rarely the right commercial partner. This isn’t a selection failure. It’s a feature of hardware startups.

The founders who handle this well don’t pick better suppliers. They plan supplier transitions the same way they plan design milestones: explicitly, on a roadmap, with lead time built in. A clinical-grade supplier typically takes three to four months to qualify. If you start that process when you need the parts, your timeline has already slipped.

The criteria shift too. If you’re qualifying a prototype supplier, the question isn’t “can they support me at commercial scale?” It’s “can they move fast, tolerate ambiguous specs, and pick up the phone when something’s wrong?” Applying commercial-stage rigor at prototype wastes months you don’t have.

Locking in a prototype supplier and hoping they’ll grow with you is the other version of the same mistake. Start the next stage’s qualification while the current relationship is still working smoothly.

Nail It, Scale It, Sail It maps the full three-stage picture: what each stage needs from a supplier, and when to start planning the transition to the next one.

Cathedral or Bazaar #

The Cathedral is built once. Every stone placed deliberately. It doesn’t move once it’s done. That’s the right approach when you know exactly what you’re building and the plan won’t change.

The alternative is a Bazaar: open, iterative, continuously re-evaluated. Not chaotic. Just alive to feedback. You qualify for the stage you’re entering, not the company you plan to become. You build explicit transitions into the roadmap. You stay willing to change the relationship when the signals tell you it’s time.

The Cathedral is right for big medtech. The Bazaar is right for you, until you’re not pre-Series A anymore.

Some suppliers grow with you through every stage. When they do, it’s because you chose them with the right criteria at the start and stayed honest about fit as you scaled. That relationship doesn’t happen by accident. It happens because you treated selection as a hire, not a procurement decision, and kept evaluating it like one.

Where to start #

Before your next RFQ, name the stage: prototype, clinical, or commercial. Each needs a different supplier profile. Then ask what signals, beyond credentials and samples, tell you whether this supplier will hold up when things change.

Nail It, Scale It, Sail It covers all three stages and how to plan the transitions before they become crises. Buy the Technical, Build the Adaptive goes deeper on the adaptive signals that credentials and samples can’t capture.

If you’re mid-qualification and something feels off, book a 1:1. Most founders who book come in thinking they need a new supplier. Sometimes they do. More often, they need to reframe the decision they’re already making.